|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Cerevel Therapeutics Hldg (NASDAQ: CERE) through any online brokerage.
The latest price target for Cerevel Therapeutics Hldg (NASDAQ: CERE) was reported by JP Morgan on January 5, 2022. The analyst firm set a price target for 50.00 expecting CERE to rise to within 12 months (a possible 97.71% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Cerevel Therapeutics Hldg (NASDAQ: CERE) is $25.29 last updated Fri Jan 21 2022 21:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Cerevel Therapeutics Hldg.
Cerevel Therapeutics Hldg’s $Q4 earnings are confirmed for after-market on March 23, 2022.
There is no upcoming split for Cerevel Therapeutics Hldg.
Cerevel Therapeutics Hldg is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.